Research ArticleGout
Febuxostat Use and Risks of Cardiovascular Disease Events, Cardiac Death, and All-cause Mortality: Metaanalysis of Randomized Controlled Trials
Hao Deng, Bao Long Zhang, Jin Dong Tong, Xiu Hong Yang and Hui Min Jin
The Journal of Rheumatology July 2021, 48 (7) 1082-1089; DOI: https://doi.org/10.3899/jrheum.200307
Hao Deng
1H. Deng, MD, X.H. Yang, MD, H.M. Jin, PhD, Division of Nephrology, Shanghai Pudong Hospital, Fudan University, Pudong Medical Center;
Bao Long Zhang
2B.L. Zhang, PhD, The Institutes of Biomedical Sciences (IBS), Fudan University;
Jin Dong Tong
3J.D. Tong, PhD, Division of Vascular Surgery, Shanghai Pudong Hospital, Fudan University, Pudong Medical Center, Shanghai, China.
Xiu Hong Yang
1H. Deng, MD, X.H. Yang, MD, H.M. Jin, PhD, Division of Nephrology, Shanghai Pudong Hospital, Fudan University, Pudong Medical Center;
Hui Min Jin
1H. Deng, MD, X.H. Yang, MD, H.M. Jin, PhD, Division of Nephrology, Shanghai Pudong Hospital, Fudan University, Pudong Medical Center;
REFERENCES
- 1.↵
- Choi HK,
- Curhan G.
- 2.↵
- 3.↵
- 4.↵
- 5.↵
- Jun JE,
- Lee YB,
- Lee SE,
- Ahn JY,
- Kim G,
- Jin SM, et al.
- 6.↵
- Tamariz L,
- Hare JM.
- 7.↵
- 8.↵ULORIC medication guide. [Internet. Accessed December 15, 2020]. Available from: general.takedapharm.com/ULORICPI
- 9.↵
- Schumacher HR Jr,
- Becker MA,
- Wortmann RL,
- Macdonald PA,
- Hunt B,
- Streit J, et al.
- 10.↵
- 11.↵
- Becker MA,
- Schumacher HR Jr,
- Wortmann RL,
- MacDonald PA,
- Palo WA,
- Eustace D, et al.
- 12.↵
- Becker MA,
- Schumacher HR,
- MacDonald PA,
- Lloyd E,
- Lademacher C.
- 13.↵
- 14.↵
- 15.↵FDA to evaluate increased risk of heart-related death and death from all causes with the gout medicine febuxostat (Uloric). [Internet. Accessed December 15, 2020]. Available from: www.fda.gov/media/108760/download
- 16.↵FDA adds Boxed Warning for increased risk of death with gout medicine Uloric (febuxostat). [Internet. Accessed December 15, 2020]. Available from: www.fda.gov/media/120418/download
- 17.↵
- Cuenca JA,
- Balda J,
- Palacio A,
- Young L,
- Pillinger MH,
- Tamariz L.
- 18.↵
- 19.↵
- Mukri MNA,
- Kong WY,
- Mustafar R,
- Shaharir SS,
- Shah SA,
- Abdul Gafor AH, et al.
- 20.↵
- Cicero AF,
- Cosentino ER,
- Kuwabara M,
- Degli Esposti D,
- Borghi C.
- 21.↵
- 22.
- Singh JA,
- Cleveland JD.
- 23.
- Chohan S,
- Becker MA,
- MacDonald PA,
- Chefo S,
- Jackson RL.
- 24.
- Spina M,
- Nagy Z,
- Ribera JM,
- Federico M,
- Aurer I,
- Jordan K, et al.
- 25.↵
- Beddhu S,
- Filipowicz R,
- Wang B,
- Wei G,
- Chen X,
- Roy AC, et al.
- 26.↵
- Nakagomi A,
- Saiki Y,
- Noma S,
- Kohashi K,
- Morisawa T,
- Kosugi M, et al.
- 27.
- Gunawardhana L,
- McLean L,
- Punzi HA,
- Hunt B,
- Palmer RN,
- Whelton A, et al.
- 28.↵
- 29.↵
- 30.↵
- Saag KG,
- Whelton A,
- Becker MA,
- MacDonald P,
- Hunt B,
- Gunawardhana L.
- 31.
- Saag KG,
- Becker MA,
- Whelton A,
- Hunt B,
- Castillo M,
- Kisfalvi K, et al.
- 32.↵
- Dalbeth N,
- Saag KG,
- Palmer WE,
- Choi HK,
- Hunt B,
- MacDonald PA, et al.
- 33.↵
- Kamatani N,
- Fujimori S,
- Hada T,
- Hosoya T,
- Kohri K,
- Nakamura T, et al.
- 34.↵
- Foody J,
- Turpin RS,
- Tidwell BA,
- Lawrence D,
- Schulman KL.
- 35.↵ICD-9-CM Official Guidelines for Coding and Reporting. [Internet. Accessed December 15, 2020]. Available from: www.findacode.com/icd-9/icd-9-cm-guidelines.html.
- 36.↵
- Long H,
- Jiang J,
- Xia J,
- Jiang R,
- He Y,
- Lin H, et al.
- 37.↵
- Wang S,
- Li Y,
- Song X,
- Wang X,
- Zhao C,
- Chen A, et al.
- 38.↵
- 39.↵
- Krishnamurthy B,
- Rani N,
- Bharti S,
- Golechha M,
- Bhatia J,
- Nag TC, et al.
- 40.↵
- Mizuno Y,
- Yamamotoya T,
- Nakatsu Y,
- Ueda K,
- Matsunaga Y,
- Inoue MK, et al.
- 41.↵
- Bove M,
- Cicero AF,
- Borghi C.
- 42.↵
In this issue
The Journal of Rheumatology
Vol. 48, Issue 7
1 Jul 2021
Febuxostat Use and Risks of Cardiovascular Disease Events, Cardiac Death, and All-cause Mortality: Metaanalysis of Randomized Controlled Trials
Hao Deng, Bao Long Zhang, Jin Dong Tong, Xiu Hong Yang, Hui Min Jin
The Journal of Rheumatology Jul 2021, 48 (7) 1082-1089; DOI: 10.3899/jrheum.200307